Atrium Therapeutics, Inc.
RNA
$13.19
$0.413.21%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | |||
| Total Receivables | 14,900.00% | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 67.95% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -88.60% | -- | |||
| Total Current Assets | 9,937.43% | -- | |||
|
|
|||||
| Total Current Assets | 9,937.43% | -- | |||
| Net Property, Plant & Equipment | 15.83% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | 3,400.06% | -- | |||
|
|
|||||
| Total Accounts Payable | -81.65% | -- | |||
| Total Accrued Expenses | 4.39% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -27.02% | -- | |||
| Total Finance Division Other Current Liabilities | -62.68% | -- | |||
| Total Other Current Liabilities | -62.68% | -- | |||
| Total Current Liabilities | -47.60% | -- | |||
|
|
|||||
| Total Current Liabilities | -47.60% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 24.21% | -- | |||
| Total Liabilities | -18.03% | -- | |||
|
|
|||||
| Common Stock & APIC | 453.96% | -- | |||
| Retained Earnings | -- | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 473.29% | 0.00% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 473.29% | 0.00% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 473.29% | 0.00% | |||
|
|
|||||